Literature DB >> 26295445

Mechanism of microglia neuroprotection: Involvement of P2X7, TNFα, and valproic acid.

Annette Masuch1, Chu-Hsin Shieh1, Nico van Rooijen2, Dietrich van Calker1, Knut Biber1,3.   

Abstract

Recently, we have demonstrated that ramified microglia are neuroprotective in N-methyl-D-aspartate (NMDA)-induced excitotoxicity in organotypic hippocampal slice cultures (OHSCs). The present study aimed to elucidate the underlying neuron-glia communication mechanism. It is shown here that pretreatment of OHSC with high concentrations of adenosine 5'-triphosphate (ATP) reduced NMDA-induced neuronal death only in presence of microglia. Specific agonists and antagonists identified the P2X7 receptor as neuroprotective receptor which was confirmed by absence of ATP-dependent neuroprotection in P2X7-deficient OHSC. Microglia replenished chimeric OHSC consisting of wild-type tissue replenished with P2X7-deficient microglia confirmed the involvement of microglial P2X7 receptor in neuroprotection. Stimulation of P2X7 in primary microglia induced tumor necrosis factor α (TNFα) release and blocking TNFα by a neutralizing antibody in OHSC abolished neuroprotection by ATP. OHSC from TNFα-deficient mice show increased exicitoxicity and activation of P2X7 did not rescue neuronal survival in the absence of TNFα. The neuroprotective effect of valproic acid (VPA) was strictly dependent on the presence of microglia and was mediated by upregulation of P2X7 in the cells. The present study demonstrates that microglia-mediated neuroprotection depends on ATP-activated purine receptor P2X7 and induction of TNFα release. This neuroprotective pathway was strengthened by VPA elucidating a novel mechanism for the neuroprotective function of VPA.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  ATP; NMDA; OHSC; cytokine; excitotoxicity; glia; hippocampus; purine receptor

Mesh:

Substances:

Year:  2015        PMID: 26295445     DOI: 10.1002/glia.22904

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  35 in total

Review 1.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

Review 2.  Purinergic system in psychiatric diseases.

Authors:  A Cheffer; A R G Castillo; J Corrêa-Velloso; M C B Gonçalves; Y Naaldijk; I C Nascimento; G Burnstock; H Ulrich
Journal:  Mol Psychiatry       Date:  2017-09-26       Impact factor: 15.992

3.  Decreased post-synaptic density-95 protein expression on dendrites of newborn neurons following CX3CR1 modulation in the epileptogenic adult rodent brain.

Authors:  Idrish Ali; Una Avdic; Deepti Chugh; Christine T Ekdahl
Journal:  Cell Mol Immunol       Date:  2017-10-30       Impact factor: 11.530

4.  Accumulation of PSA-NCAM marks nascent neurodegeneration in the dorsal hippocampus after neonatal hypoxic-ischemic brain injury in mice.

Authors:  Raul Chavez-Valdez; Charles Lechner; Paul Emerson; Frances J Northington; Lee J Martin
Journal:  J Cereb Blood Flow Metab       Date:  2020-07-23       Impact factor: 6.200

5.  Sodium valproate ameliorates memory impairment and reduces the elevated levels of apoptotic caspases in the hippocampus of diabetic mice.

Authors:  Parvin Zareie; Mahsa Gholami; Behnam Amirpour-Najafabadi; Sirvan Hosseini; Mehdi Sadegh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-07-04       Impact factor: 3.000

Review 6.  Microglia Function in the Central Nervous System During Health and Neurodegeneration.

Authors:  Marco Colonna; Oleg Butovsky
Journal:  Annu Rev Immunol       Date:  2017-02-09       Impact factor: 28.527

7.  [11C]JNJ54173717, a novel P2X7 receptor radioligand as marker for neuroinflammation: human biodistribution, dosimetry, brain kinetic modelling and quantification of brain P2X7 receptors in patients with Parkinson's disease and healthy volunteers.

Authors:  Donatienne Van Weehaeghe; Michel Koole; Mark E Schmidt; Stephanie Deman; Andreas H Jacobs; Erika Souche; Kim Serdons; Stefan Sunaert; Guy Bormans; Wim Vandenberghe; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-06-26       Impact factor: 9.236

Review 8.  Intracellular Signaling Cascades in Bipolar Disorder.

Authors:  Gregory H Jones; Carola Rong; Aisha S Shariq; Abhinav Mishra; Rodrigo Machado-Vieira
Journal:  Curr Top Behav Neurosci       Date:  2021

9.  Age-related myelin degradation burdens the clearance function of microglia during aging.

Authors:  Shima Safaiyan; Nirmal Kannaiyan; Nicolas Snaidero; Simone Brioschi; Knut Biber; Simon Yona; Aimee L Edinger; Steffen Jung; Moritz J Rossner; Mikael Simons
Journal:  Nat Neurosci       Date:  2016-06-13       Impact factor: 24.884

Review 10.  Repurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's disease.

Authors:  Edward C Lauterbach
Journal:  Am J Neurodegener Dis       Date:  2016-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.